Home > Income Statement > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Revenue

    Back to Income Statement
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹10,728 Cr₹9,620 Cr₹8,508 Cr₹8,005 Cr₹7,939 Cr

What is the latest Revenue of TORRENT PHARMACEUTICALS ?

The latest Revenue ratio of TORRENT PHARMACEUTICALS is ₹10,728 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹10,728 Cr
Mar2024₹9,620 Cr
Mar2023₹8,508 Cr
Mar2022₹8,005 Cr
Mar2021₹7,939 Cr

How is Revenue of TORRENT PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2025 ₹10,728 Cr
11.51
Mar2024 ₹9,620 Cr
13.07
Mar2023 ₹8,508 Cr
6.29
Mar2022 ₹8,005 Cr
0.82
Mar2021 ₹7,939 Cr -

Compare Revenue of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹133,872.7 Cr -0.7% 3.8% 26.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,329.0 Cr -0.2% -6.3% -8.8% Stock Analytics
DIVIS LABORATORIES ₹164,674.0 Cr 3.3% -3.4% 4% Stock Analytics
CIPLA ₹107,292.0 Cr -3% -11.8% -8.8% Stock Analytics
DR REDDYS LABORATORIES ₹102,184.0 Cr 6% -3.5% -4.3% Stock Analytics
MANKIND PHARMA ₹87,333.0 Cr 0.8% -3.5% -16.7% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

-0.7%

3.8%

26.3%

SENSEX

0.2%

-3.6%

8.6%


You may also like the below Video Courses